On the other hand, they showed that patients with ovarian carcinoma stage III-IV had higher levels of IL-8 than patients in stage I-II, which suggests that the IL-8 serum level is related to the clinical stage or pathological type of the cancer. Here, CXCL8 is linked to ovarian carcinoma.